CLINICAL_TRIALS
research
· 2024-06-28
Clinical Trial Update: FET-PET-Guided Management of Pseudoprogression in Glioblastoma [NA]
Summary
A clinical trial studying FET-PET-guided management of pseudoprogression in glioblastoma, with recruitment not yet started.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Veerle Ruijters | Conditions: Glioblastoma, Radionecrosis of Brain | NA | Status: NOT_YET_RECRUITING